Edgewise Therapeutics, Inc. (EWTX)
30.44
+0.78
(+2.63%)
USD |
NASDAQ |
Feb 27, 16:00
30.15
-0.29
(-0.95%)
Pre-Market: 09:12
Edgewise Therapeutics Total Liabilities (Quarterly) : 30.35M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Glaukos Corp. | 274.22M |
| Nuvalent, Inc. | 164.37M |
| Neurocrine Biosciences, Inc. | 1.500B |
| Omeros Corp. | 406.18M |
| Agios Pharmaceuticals, Inc. | 104.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 552.60M |
| Shareholders Equity (Quarterly) | 522.26M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 19.85 |
| Net Debt Paydown Yield | 0.00% |